Sunshine Biopharma cuts warrant exercise price to 1.2
SBFM•Warrant exercise price reduced
Sunshine Biopharma cut the exercise price on its outstanding Series B Warrants to $1.2.
- Reset reflects recent common stock sales under the company’s previously disclosed at-the-market offering.
- Exercise price remains subject to further adjustment under the Series B Warrants terms.
